Johnson & Johnson vaccine: Rollout delayed in Europe over blood clot fears - latest
THE ROLLOUT of the Johnson & Johnson vaccine in Europe has been "proactively" delayed while blood clot links are being investigated, the pharmaceutical giant has revealed. The news comes after pressure by US health authorities to forestall the rollout.